OKYO Prakiraan wutah bathi resik saben saham ing taun iki OKYO Pharma Limited

Lambang korporat lan logo okyopharma.com (OKYO)

OKYO Pharma Limited is developing advanced eye drops to combat dry eye by targeting the neural mechanisms of inflammation. The company focuses on ophthalmology centers, utilizing non-peptide antagonists for corneal therapy. The current pipeline is centered on preparing critical Phase II trial data. The year-over-year percentage change in EPS demonstrates a pivot, and the value of 20.90 reflects this status of the issuer's financial dynamics.

Wutah bathi saben saham ing taun lumaku: OKYO Pharma (OKYO) kanggo 27.06.2023 - 17.11.2026

Rincian analitis lan laporan data perusahaan okyopharma.com (OKYO)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:okyopharma.com (OKYO)
Produk mawa merek OKYO Pharma Limited

Investors assess the financial stability of the issuer through earnings per share dynamics. This indicator calculates the percentage deviation of the current EPS from the previous year's value, measuring the speed of capital recovery. For OKYO Pharma (OKYO), whose ophthalmological developments are independent of market cycles, this parameter reflects pure scientific progress. The annual EPS growth trend allows for the verification of the business recovery pace. Analyzing this trajectory eliminates the risk of overpaying for unconfirmed successes.